Related Experiment Video
Updated: May 12, 2026

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice
Published on: August 23, 2019
Notch pathway is activated by MAPK signaling and influences papillary thyroid cancer proliferation
Alex Shimura Yamashita1, Murilo Vieira Geraldo, Cesar Seigi Fuziwara
1Department of Cell and Developmental Biology, Institute of Biomedical Sciences, University of São Paulo, Sã Paulo, Brazil.
Abstract:
Mutually exclusive genetic alterations in the RET, RAS, or BRAF genes, which result in constitutively active mitogen-activated protein kinase (MAPK) signaling, are present in about 70% of papillary thyroid carcinomas (PTCs). However, the effect of MAPK activation on other signaling pathways involved in oncogenic transformation, such as Notch, remains unclear. In this study, we tested the hypothesis that the MAPK pathway regulates Notch signaling and that Notch signaling plays a role in PTC cell proliferation. Conditional induction of MAPK signaling oncogenes RET/PTC3 or BRAF(T1799A) in normal rat thyroid cell line mediated activation of Notch signaling, upregulating Notch1 receptor and Hes1, the downstream effector of Notch pathway. Conversely, pharmacological inhibition of MAPK reduced Notch signaling in PTC cell. Thyroid tumor samples from transgenic mice expressing BRAF(T1799A) and primary human PTC samples showed high levels of Notch1 expression. Down-regulation of Notch signaling by γ-secretase inhibitor (GSI) or NOTCH1 RNA interference reduces PTC cell proliferation. Moreover, the combination of GSI with a MAPK inhibitor enhanced the growth suppression in PTC cells. This study revealed that RET/PTC and BRAF(T1799A) activate Notch signaling and promote tumor growth in thyroid follicular cell. Taken together, these data suggest that Notch signaling may be explored as an adjuvant therapy for thyroid papillary cancer.
Insights
Mitogen-activated protein kinase (MAPK) pathway activation drives papillary thyroid cancer (PTC) by upregulating Notch signaling. Inhibiting Notch or MAPK pathways suppressed PTC cell growth, suggesting Notch as a potential therapeutic target.
Area of Science:
- Oncology
- Molecular Biology
- Cell Signaling
Background:
- Papillary thyroid carcinomas (PTCs) frequently exhibit activated mitogen-activated protein kinase (MAPK) signaling due to genetic alterations in RET, RAS, or BRAF.
- The impact of MAPK pathway activation on other oncogenic pathways, like Notch signaling, in PTC remains largely uncharacterized.
Purpose of the Study:
- To investigate if the MAPK pathway regulates Notch signaling in PTC.
- To determine the role of Notch signaling in PTC cell proliferation.
Main Methods:
- Conditional induction of MAPK signaling oncogenes (RET/PTC3, BRAF(T1799A)) in rat thyroid cells.
- Pharmacological inhibition of MAPK and Notch signaling (using γ-secretase inhibitor - GSI).
- Analysis of Notch1 and Hes1 expression in cell lines and tumor samples; assessment of PTC cell proliferation.
Main Results:
- MAPK activation (RET/PTC3, BRAF(T1799A)) led to increased Notch signaling, evidenced by elevated Notch1 receptor and Hes1 expression.
- MAPK inhibition reduced Notch signaling in PTC cells.
- High Notch1 expression was observed in BRAF(T1799A) transgenic mouse tumors and human PTC samples.
- Down-regulating Notch signaling (via GSI or NOTCH1 RNA interference) decreased PTC cell proliferation.
- Combined GSI and MAPK inhibition synergistically suppressed PTC cell growth.
Conclusions:
- RET/PTC and BRAF(T1799A) oncogenes activate Notch signaling, contributing to thyroid follicular cell tumor growth.
- Notch signaling represents a potential therapeutic target for adjuvant therapy in papillary thyroid cancer.
Related Concept Videos
Notch Signaling Pathway
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not until 1985...
Notch Signaling Pathway
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not until 1985...
MAPK Signaling Cascades
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Role Of Notch Signalling In Intestinal Stem Cell Renewal
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...

